Prospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. May 7, 2024; 30(17): 2343-2353
Published online May 7, 2024. doi: 10.3748/wjg.v30.i17.2343
Figure 1
Figure 1 Receiver operating characteristic curves displaying the diagnostic performances of GALAD and other biomarkers. A: On staging curative hepatocellular carcinoma; B: On aggressive features of hepatocellular carcinoma; C: On 1-year mortality of hepatocellular carcinoma. AFP: Alpha-fetoprotein; AFP-L3: Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein; AUC: Area under the curve; PIVKA II: Protein induced by vitamin K absence – II.